|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||111.37 - 111.37|
|52-week range||97.56 - 124.40|
|PE ratio (TTM)||24.79|
|Forward Dividend & Yield||1.31 (1.16%)|
|1y target est||N/A|
FRANKFURT/LONDON, Sept 8 (Reuters) - Germany's Merck KGaA has hired JP Morgan to sell its consumer health business, which includes brands such as Seven Seas vitamins and could be worth around $4.5 billion. The family-controlled drugmaker said on Tuesday it was considering selling the business, whose sales of over-the-counter medicines and vitamin supplements are about $1 billion a year, to help fund research into higher-margin prescription drugs.
FRANKFURT/COLOGNE, Sept 5 (Reuters) - Germany's Merck KGaA (LSE: 0O14.L - news) is considering selling its consumer healthcare business which has sales of $1 billion a year to help fund more research into prescription drugs and amid declines in the company's separate liquid crystal business. The company said on Tuesday that to remain competitive the consumer healthcare business would need further investment and therefore it was considering a sale or strategic partnership instead, adding that a review process was at an early stage with a final decision expected to be made early next year. Fully anticipating this, we are preparing strategic options," Belen Garijo, chief executive of Merck's entire Healthcare (Shanghai: 603313.SS - news) division, said in a statement.
Dark web intelligence, bio-authorization and even plain old cloud security: Cybersecurity commands a futuristic and slightly dystopian-sounding lexicon.
DGAP-News: VAXIMM AG / Key word(s): Alliance09.05.2017 / 08:30 The issuer is solely responsible for the content of this announcement. ...